Rani Therapeutics Holdings (RANI) Profit After Tax (2020 - 2025)
Historic Profit After Tax for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to -$7.9 million.
- Rani Therapeutics Holdings' Profit After Tax rose 3779.28% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.6 million, marking a year-over-year increase of 1329.83%. This contributed to the annual value of -$56.6 million for FY2024, which is 1662.12% up from last year.
- According to the latest figures from Q3 2025, Rani Therapeutics Holdings' Profit After Tax is -$7.9 million, which was up 3779.28% from -$11.2 million recorded in Q2 2025.
- Rani Therapeutics Holdings' 5-year Profit After Tax high stood at -$5.5 million for Q2 2021, and its period low was -$28.7 million during Q3 2021.
- Moreover, its 5-year median value for Profit After Tax was -$14.1 million (2023), whereas its average is -$14.4 million.
- As far as peak fluctuations go, Rani Therapeutics Holdings' Profit After Tax plummeted by 89549.08% in 2021, and later surged by 4352.61% in 2022.
- Rani Therapeutics Holdings' Profit After Tax (Quarter) stood at -$13.3 million in 2021, then tumbled by 30.34% to -$17.3 million in 2022, then rose by 18.95% to -$14.1 million in 2023, then dropped by 11.97% to -$15.7 million in 2024, then skyrocketed by 49.71% to -$7.9 million in 2025.
- Its last three reported values are -$7.9 million in Q3 2025, -$11.2 million for Q2 2025, and -$12.7 million during Q1 2025.